Portfolio (Quarterly)
Guide ↗
UBS Group AG
· CIK 0001610520| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 8541 | BNDS | SERIES PORTFOLIOS TR | — | 159.0 | $8K | — | NEW | — | $49.67 | +2.6% |
| 8542 | COHN | COHEN & CO INC NEW | Financial Services | 522.0 | $8K | — | NEW | — | $15.09 | -25.1% |
| 8543 | — | EQV VENTURES AC CORP. II | — | 780.0 | $8K | — | +557.0 | +249.8% | $10.09 | — |
| 8544 | — | ELUTIA INC | — | 7,487.0 | $8K | — | +7K | +10000.0% | $1.05 | — |
| 8545 | FLQS | FRANKLIN TEMPLETON ETF TR | — | 184.0 | $8K | — | NEW | — | $42.68 | +6.7% |
| 8546 | PCGG | LITMAN GREGORY FDS TR | — | 781.0 | $8K | — | NEW | — | $10.04 | +9.3% |
| 8547 | — | COLLABORATIVE INVESTMNT SER | — | 252.0 | $8K | — | -303.0 | -54.6% | $31.08 | — |
| 8548 | DSMC | ETF SER SOLUTIONS | — | 209.0 | $8K | — | +137.0 | +190.3% | $37.43 | +5.5% |
| 8549 | — | MOLECULIN BIOTECH INC | — | 3,409.0 | $8K | — | -2K | -41.9% | $2.29 | — |
| 8550 | ELAB | PMGC HLDGS INC | Healthcare | 1,302.0 | $8K | — | NEW | — | $5.99 | -70.3% |
| 8551 | APMU | TRUST FOR PROFESSIONAL MANAG | — | 313.0 | $8K | — | +255.0 | +439.7% | $24.89 | -0.3% |
| 8552 | CYCU | CYCURION INC | Technology | 7,689.0 | $8K | — | +2K | +41.5% | $1.01 | -0.0% |
| 8553 | FMCX | NORTHERN LTS FD TR IV | — | 242.0 | $8K | — | -112.0 | -31.6% | $32.09 | +14.0% |
| 8554 | — | TIDAL TRUST II | — | 374.0 | $8K | — | NEW | — | $20.76 | — |
| 8555 | — | RF ACQUISITION CORP II | — | 939.0 | $8K | — | -471.0 | -33.4% | $8.26 | — |
| 8556 | TUSB | THRIVENT ETF TRUST | — | 154.0 | $8K | — | NEW | — | $50.29 | +0.6% |
| 8557 | — | YORKVILLE ACQUISITION CORP. | — | 765.0 | $8K | — | -3K | -80.2% | $10.11 | — |
| 8558 | NXL | NEXALIN TECHNOLOGY INC | Healthcare | 22,189.0 | $8K | — | +6K | +39.5% | $0.35 | +8.5% |
| 8559 | BMGL | BASEL MED GROUP LTD | Healthcare | 13,056.0 | $8K | — | +5K | +61.4% | $0.59 | +1.2% |
| 8560 | — | ETF OPPORTUNITIES TRUST | — | 270.0 | $8K | — | +198.0 | +275.0% | $28.47 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
27.2%
Financial Services
17.5%
Industrials
11.0%
Healthcare
9.8%
Consumer Cyclical
9.1%
Communication Services
7.5%
Energy
5.5%
Consumer Defensive
4.8%
Basic Materials
2.7%
Utilities
2.7%